Legal Representation
Attorney
Romy Corliss
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 21, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Mar 21, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 7, 2005 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Nov 7, 2005 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 25, 2005 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 13, 2005 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 13, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 26, 2005 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 11, 2005 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 11, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 13, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 20, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 31, 2004 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 31, 2004 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Feb 10, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 15, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 15, 2004 | I | PAPER RECEIVED | Loading... | |
| Aug 19, 2003 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Aug 12, 2003 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, anti-infectives and antifungal and antibiotic agents; pharmaceutical preparations for the treatment of infections
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical research and analysis services
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS" and "VITAL MEDICINE FOR SERIOUSLY ILL PATIENTS"